ArticleBMJ open2024

Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer.

Uma Anne Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.